Cost of ‘game changer’ MND drug slashed from $28k to $25 after listing on PBS

Key Takeaways

• Tofersen (Qalsody) will be listed on PBS for MND patients with ALS
• The cost of Tofersen (Qalsody) will be reduced from $28,600 to $25 per script
• About 70 eligible patients will benefit from the reduced cost
• 90% of MND cases are affected by ALS
• Approximately 2800 Australians are affected by ALS
• Concessional patients will pay $7.70 per script